CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 92 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $649,000 | +29.0% | 51,348 | +0.3% | 0.00% | – |
| Q3 2020 | $503,000 | +269.9% | 51,207 | +351.2% | 0.00% | – |
| Q2 2019 | $136,000 | +9.7% | 11,349 | +10.6% | 0.00% | – |
| Q1 2019 | $124,000 | -12.7% | 10,260 | -9.1% | 0.00% | – |
| Q4 2018 | $142,000 | -77.0% | 11,288 | -72.9% | 0.00% | -100.0% |
| Q3 2018 | $618,000 | -56.0% | 41,668 | -50.1% | 0.00% | 0.0% |
| Q2 2018 | $1,405,000 | -29.2% | 83,490 | -3.7% | 0.00% | -50.0% |
| Q1 2018 | $1,985,000 | +168.6% | 86,671 | +203.4% | 0.00% | +100.0% |
| Q4 2017 | $739,000 | +370.7% | 28,563 | +169.1% | 0.00% | – |
| Q3 2017 | $157,000 | – | 10,616 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| L1 Capital Pty Ltd | 1,050,124 | $10,312,000 | 3.31% |
| Alambic Investment Management, L.P. | 19,934 | $196,000 | 2.15% |
| INGALLS & SNYDER LLC | 1,363,603 | $13,391,000 | 0.92% |
| ACUTA CAPITAL PARTNERS, LLC | 300,000 | $2,946,000 | 0.80% |
| RA Capital Management | 1,858,474 | $18,250,000 | 0.33% |
| Perceptive Advisors | 2,150,641 | $21,119,000 | 0.31% |
| SPHERA FUNDS MANAGEMENT LTD. | 310,000 | $3,044,000 | 0.30% |
| Eversept Partners, LP | 103,829 | $1,019,601 | 0.23% |
| Opaleye Management Inc. | 100,000 | $982,000 | 0.19% |
| GSA CAPITAL PARTNERS LLP | 58,095 | $570,000 | 0.10% |